Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.
Back to Business
Business
September 30, 2026 at 5:58 PM
This New Drug Could Solve the GLP-1 Plateau Problem
Inc.
Excerpt from Inc..
